DK0610134T3 - Indolderivater som 5-HT,1-lignende agonister - Google Patents
Indolderivater som 5-HT,1-lignende agonisterInfo
- Publication number
- DK0610134T3 DK0610134T3 DK94400215T DK94400215T DK0610134T3 DK 0610134 T3 DK0610134 T3 DK 0610134T3 DK 94400215 T DK94400215 T DK 94400215T DK 94400215 T DK94400215 T DK 94400215T DK 0610134 T3 DK0610134 T3 DK 0610134T3
- Authority
- DK
- Denmark
- Prior art keywords
- image
- alkyl
- group
- hydrogen atom
- agonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9301054A FR2701026B1 (fr) | 1993-02-02 | 1993-02-02 | Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0610134T3 true DK0610134T3 (da) | 2000-08-21 |
Family
ID=9443592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK94400215T DK0610134T3 (da) | 1993-02-02 | 1994-02-02 | Indolderivater som 5-HT,1-lignende agonister |
Country Status (14)
Country | Link |
---|---|
US (1) | US5348968A (ja) |
EP (1) | EP0610134B1 (ja) |
JP (1) | JP2614981B2 (ja) |
AT (1) | ATE191481T1 (ja) |
AU (1) | AU669032B2 (ja) |
CA (1) | CA2114593C (ja) |
DE (1) | DE69423802T2 (ja) |
DK (1) | DK0610134T3 (ja) |
ES (1) | ES2147223T3 (ja) |
FR (1) | FR2701026B1 (ja) |
GR (1) | GR3033505T3 (ja) |
NZ (1) | NZ250800A (ja) |
PT (1) | PT610134E (ja) |
ZA (1) | ZA94709B (ja) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5559246A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc. | Indole derivatives |
US5607951A (en) * | 1990-10-15 | 1997-03-04 | Pfizer Inc | Indole derivatives |
US5578612A (en) * | 1990-10-15 | 1996-11-26 | Pfizer Inc. | Indole derivatives |
US5545644A (en) * | 1990-10-15 | 1996-08-13 | Pfizer Inc. | Indole derivatives |
US5559129A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc | Indole derivatives |
ATE190608T1 (de) * | 1991-11-25 | 2000-04-15 | Pfizer | 5-(hetero- oder carbocyclylamino)-indol derivate, deren herstellung und deren verwendung als 5-ht1 agonisten |
ES2122289T3 (es) * | 1993-08-31 | 1998-12-16 | Pfizer | Derivados de 5-arilindol. |
DK139593D0 (da) * | 1993-12-16 | 1993-12-16 | Lundbeck & Co As H | Compounds |
US6423731B2 (en) * | 1994-01-06 | 2002-07-23 | Zeneca Limited | Indole derivatives as prodrugs of 5-HT1-like receptor agonists |
PT765322E (pt) * | 1994-06-01 | 2002-01-30 | Astrazeneca Ab | Derivados indole pro-farmacos de agonistas de receptores tipo 5-ht1 |
GB9417310D0 (en) * | 1994-08-27 | 1994-10-19 | Pfizer Ltd | Therapeutic agents |
AU726560B2 (en) * | 1994-10-12 | 2000-11-09 | Pfizer Research And Development Company, N.V./S.A. | Use of indole derivatives for the treatment of various diseases |
GB9420529D0 (en) * | 1994-10-12 | 1994-11-30 | Pfizer Ltd | Indoles |
FR2735129B1 (fr) * | 1995-06-07 | 1997-07-11 | Adir | Nouveaux derives de l'indole, de l'indazole et du benzisoxazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US5856510A (en) * | 1996-12-16 | 1999-01-05 | Allelix Biopharmaceuticals Inc. | 5-alkenyl and 5-alkynyl indole compounds |
US5998462A (en) * | 1996-12-16 | 1999-12-07 | Allelix Biopharmaceuticals Inc. | 5-alkyl indole compounds |
US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
US5994352A (en) * | 1998-11-13 | 1999-11-30 | Pfizer Inc. | 5-arylindole derivatives |
FR2799463B1 (fr) * | 1999-10-12 | 2004-04-16 | Adir | Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent |
WO2002051832A2 (en) * | 2000-12-22 | 2002-07-04 | Wyeth | Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands |
US7196082B2 (en) | 2002-11-08 | 2007-03-27 | Merck & Co. Inc. | Ophthalmic compositions for treating ocular hypertension |
US20060154897A1 (en) * | 2002-11-08 | 2006-07-13 | Doherty James B | Ophthalmic compositions for treating ocular hypertension |
WO2004050634A1 (en) * | 2002-12-02 | 2004-06-17 | F. Hoffmann-La Roche Ag | Indazole derivatives as crf antagonists |
EP1651232B1 (en) * | 2003-07-23 | 2010-12-22 | Synta Pharmaceuticals Corporation | Compounds for inflammation and immune-related uses |
TW200616967A (en) | 2004-06-24 | 2006-06-01 | Smithkline Beecham Corp | Novel indazole carboxamides and their use |
PE20060748A1 (es) | 2004-09-21 | 2006-10-01 | Smithkline Beecham Corp | Derivados de indolcarboxamida como inhibidores de quinasa ikk2 |
MX2007006408A (es) | 2004-11-29 | 2007-06-22 | Warner Lambert Co | Pirazolo[3,4-b]piridinas e indazoles terapeuticos. |
DE102005026194A1 (de) * | 2005-06-06 | 2006-12-07 | Grünenthal GmbH | Substituierte N-Benzo[d]isoxazol-3-yl-amin-Derivate und deren Verwendung zur Herstellung von Arzneimitteln |
US8063071B2 (en) | 2007-10-31 | 2011-11-22 | GlaxoSmithKline, LLC | Chemical compounds |
CN101583593A (zh) * | 2006-11-13 | 2009-11-18 | 辉瑞产品公司 | 二芳基、二吡啶基和芳基-吡啶基衍生物及其用途 |
PE20081889A1 (es) | 2007-03-23 | 2009-03-05 | Smithkline Beecham Corp | Indol carboxamidas como inhibidores de ikk2 |
JP2012520257A (ja) | 2009-03-10 | 2012-09-06 | グラクソ グループ リミテッド | Ikk2阻害剤としてのインドール誘導体 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES8301210A1 (es) * | 1980-08-12 | 1982-12-01 | Glaxo Group Ltd | Un procedimiento para la preparacion de un derivado del indol. |
GB8903036D0 (en) * | 1989-02-10 | 1989-03-30 | Glaxo Group Ltd | Chemical compounds |
YU48855B (sh) * | 1990-06-07 | 2002-06-19 | The Wellcome Foundation Limited | Heterociklična jedinjenja i njihovi derivati koji su modifikatori dejstva 5-hidroksi-triptamina i postupak njihovog dobijanja |
AU651637B2 (en) * | 1990-10-15 | 1994-07-28 | Pfizer Inc. | Indole derivatives |
EP0494774A1 (en) * | 1991-01-11 | 1992-07-15 | MERCK SHARP & DOHME LTD. | Indazole-substituted fivemembered heteroaromatic compounds |
SK278998B6 (sk) * | 1991-02-01 | 1998-05-06 | Merck Sharp & Dohme Limited | Deriváty imidazolu, triazolu a tetrazolu, spôsob i |
JPH06508354A (ja) * | 1991-06-21 | 1994-09-22 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | トリプタミン類似体、その合成法およびその5−ht↓1様または5−ht↓2受容体作用物質としての使用 |
-
1993
- 1993-02-02 FR FR9301054A patent/FR2701026B1/fr not_active Expired - Fee Related
-
1994
- 1994-01-31 CA CA002114593A patent/CA2114593C/fr not_active Expired - Fee Related
- 1994-01-31 AU AU54817/94A patent/AU669032B2/en not_active Ceased
- 1994-02-01 NZ NZ250800A patent/NZ250800A/en unknown
- 1994-02-01 JP JP6010419A patent/JP2614981B2/ja not_active Expired - Fee Related
- 1994-02-01 US US08/189,798 patent/US5348968A/en not_active Expired - Fee Related
- 1994-02-02 AT AT94400215T patent/ATE191481T1/de not_active IP Right Cessation
- 1994-02-02 DE DE69423802T patent/DE69423802T2/de not_active Expired - Fee Related
- 1994-02-02 ES ES94400215T patent/ES2147223T3/es not_active Expired - Lifetime
- 1994-02-02 ZA ZA94709A patent/ZA94709B/xx unknown
- 1994-02-02 PT PT94400215T patent/PT610134E/pt unknown
- 1994-02-02 DK DK94400215T patent/DK0610134T3/da active
- 1994-02-02 EP EP94400215A patent/EP0610134B1/fr not_active Expired - Lifetime
-
2000
- 2000-05-25 GR GR20000401196T patent/GR3033505T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69423802D1 (de) | 2000-05-11 |
CA2114593C (fr) | 2002-04-16 |
NZ250800A (en) | 1995-03-28 |
DE69423802T2 (de) | 2000-11-09 |
EP0610134A1 (fr) | 1994-08-10 |
JPH06271571A (ja) | 1994-09-27 |
EP0610134B1 (fr) | 2000-04-05 |
ZA94709B (en) | 1994-09-06 |
GR3033505T3 (en) | 2000-09-29 |
FR2701026B1 (fr) | 1995-03-31 |
US5348968A (en) | 1994-09-20 |
ATE191481T1 (de) | 2000-04-15 |
PT610134E (pt) | 2000-07-31 |
ES2147223T3 (es) | 2000-09-01 |
AU5481794A (en) | 1994-08-04 |
AU669032B2 (en) | 1996-05-23 |
CA2114593A1 (fr) | 1994-08-03 |
JP2614981B2 (ja) | 1997-05-28 |
FR2701026A1 (fr) | 1994-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0610134T3 (da) | Indolderivater som 5-HT,1-lignende agonister | |
ATE254612T1 (de) | Zuckerderivate, geliermittel, geliermittelzubereitungen, verfahren zu ihrer herstellung und gelzubereitungen | |
DE3882614D1 (de) | Indol-derivate. | |
NO20101069L (no) | Anvendelse av visse NMDA-affinitetsantagonister som antidepressiva | |
DK391289A (da) | Indolderivater | |
DE69434198D1 (de) | Verfahren zur senkung des serumcholesterinspiegels mit 2,6-dialkyl-4 silyl-phenol derivaten | |
SE8400239D0 (sv) | Nya arylettiksyraderivat | |
AT389108B (de) | Neue pyridazinonderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
MX9203360A (es) | Derivados de hexahidroazepinas y composiciones farmaceuticas que los contienen. | |
FI884088A (fi) | Foerfarande foer framstaellning av 17-substituerade androsta-1,4-dien-3-onderivat. | |
ATE111460T1 (de) | 2-(aminoalkyl)-5-(arylalkyl)1,3-dioxanderivate, ihre herstellung und ihre anwendung in der therapeutik. | |
NO961797L (no) | Anvendelse av benzopyranderivater for fremstilling av farmasöytiske sammensetninger beregnet for behandling av patologier forbundet med den Na+-uavhengige C1-HCO3-utbytter | |
DE69311500D1 (de) | 2,3-Diphenyl-5-pyrrolyl-furan Derivate, Verfahren und Zwischenprodukte für ihre Herstellung und ihre Verwendung als entzündungshemmende, antiallergische und blutplättchenaggregationshemmende Mittel | |
PT76335A (de) | Neue basisch substituierte 4-phenyl-4,5,6,7-tetrahydro-thieno-<2,3-c>pyridine verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
DE59712053D1 (de) | 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung | |
HUP9700954A2 (hu) | Szubsztituált 1-naftoil-guanidin-származékok, előállításuk, valamint az e vegyületeket tartalmazó gyógyszerkészítmények | |
NO304314B1 (no) | Cykloheksanderivater og anvendelse av forbindelsene for fremstilling av legemidler | |
ATE192141T1 (de) | Aromatische hydroxamsäure-verbindungen, ihre herstellung und verwendung | |
IE892294L (en) | Cycloalkylthiazole derivatives | |
ES2045514T3 (es) | Utilizacion de derivados del cromano para el tratamiento de los estados depresivos. | |
DE3764918D1 (de) | 2,6-piperazin-dion-derivate, ihre verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
ATE203533T1 (de) | INDOLDERIVATE ALS PRODRUGS VON ß5-HT1-LIKEß REZEPTOR AGONISTEN | |
NO165593C (no) | Analogifremgangsmaate ved fremstilling av nye tetracykliske indolderivater. | |
DE59712054D1 (de) | 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung | |
ATE28192T1 (de) | 4-alkylimidazol-derivate, ihre herstellung und verwendung. |